The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial (Q78800303)
Jump to navigation
Jump to search
scientific article published on 01 January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial |
scientific article published on 01 January 2003 |
Statements
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial (English)
S Keating
S Suciu
T de Witte
R Zittoun
F Mandelli
A Belhabri
W Fibbe
E Gallo
G Fillet
B Varet
G Meloni
A Hagemeijer
P Fazi
G Solbu
R Willemze
EORTC Leukemia Group
GIMEMA Leukemia Group